Related Experiment Videos
Evaluation of thyroid function in lithium-naive bipolar patients
J Valle1, J L Ayuso-Gutierrez, A Abril
1Department of Psychiatry, Hospital de la Princesa, Madrid, Spain.
Summary
Thyroid hypofunction is less common in bipolar patients not treated with lithium or carbamazepine. Bipolar II patients showed higher TSH levels, suggesting a potential biological difference.
Area of Science:
- Endocrinology
- Psychiatry
- Neuroscience
Background:
- Previous studies reported high thyroid hypofunction in bipolar patients, often confounded by lithium/carbamazepine treatment.
- Lithium and carbamazepine are known to affect thyroid function, potentially explaining prior findings.
Purpose of the Study:
- To investigate thyroid function in bipolar patients treatment-naïve to lithium and carbamazepine.
- To determine if thyroid dysfunction is intrinsically linked to bipolar disorder or medication effects.
Main Methods:
- Assessed serum total thyroxine (T4), total triiodothyronine (T3), and thyrotropin (TSH) levels.
- Included basal and TRH-stimulated TSH measurements in treatment-naïve bipolar patients meeting Research Diagnostic Criteria.
- Compared thyroid function across illness duration, inpatient/outpatient status, episode frequency, and cycling patterns.
Main Results:
- Thyroid hypofunction prevalence was 9.2%, significantly lower than in medicated bipolar populations.
- Five patients (9.2%) exhibited thyroid hyperfunction.
- No significant differences in thyroid indices were found based on illness duration, setting, episode count, or cycling speed.
- Bipolar II patients demonstrated statistically higher mean TSH levels compared to Bipolar I patients.
Conclusions:
- Thyroid dysfunction in bipolar disorder is not solely attributable to lithium or carbamazepine.
- Thyroid function appears unrelated to illness duration, episode frequency, or rapid cycling.
- Elevated TRH-stimulated TSH in bipolar II patients may represent a specific biological marker.